Hudson Bay Capital Management
NXTC icon

Hudson Bay Capital Management’s NextCure NXTC Stock Holding History

Hudson Bay Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,973
Closed -$83K – 1427
2024
Q4 		$83K Hold
8,973
– – ﹤0.01% 837
2024
Q3 		$148K Sell
8,973
-8,010
-47% -$147K ﹤0.01% 755
2024
Q2 		$324K Hold
16,983
– – ﹤0.01% 656
2024
Q1 		$454K Buy
+16,983
New +$293K ﹤0.01% 586

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hudson Bay Capital Management's NXTC Position: Q1 2025 in Review

Hudson Bay Capital Management sold out of NextCure (NXTC) in Q1 2025, closing a stake of 8,973 shares — an estimated $83K sold.

Hudson Bay Capital Management first reported a position in NXTC in Q1 2024 and held it in 4 quarters. The position peaked at $454K in Q1 2024. 38 funds tracked by Wall St. Rank hold NXTC as of Q1 2025.

  • Hudson Bay Capital Management reported no remaining NextCure position as of Q1 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 8,973 NextCure shares in Q1 2025, an estimated $83K.
  • Hudson Bay Capital Management first reported a position in NextCure in Q1 2024 and held it in 4 quarters.
  • Hudson Bay Capital Management's NextCure position peaked at $454K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held NextCure as of Q1 2025.

Based on Hudson Bay Capital Management's 13F filing for Q1 2025, filed 14 May 2025.